Breast Cancer
More testing methods OK'd to select patients who may benefit from Herceptin
Published in Women's Health Weekly, November 25th, 2004
HER2-positive breast cancer patients suffer from a particularly aggressive form of breast cancer with a poor prognosis. Herceptin is the only targeted treatment for HER2-positive breast cancer with demonstrated improved survival, so early and accurate determination of HER2 status is imperative.
"The approved use of a wider range of diagnostic tests will provide more options and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Bacterial Vaginosis
Bacteria more likely to develop resistance to clindamycin than metronidazole - Breast Cancer
Fruits, vegetables may decrease some women's risk of ER-positive cancer - Cervical Cancer
Study: No justification for colposcopy in screening of young women - Heart Surgery
Women at greater risk of leg infection after heart surgery than men - Systemic Lupus Erythematosus
Newly identified biomarkers could lead to quicker, better diagnosis of lupus - Abortion
Abortion clinic says it will not require parental consent - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
